Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.390
-0.020 (-0.45%)
At close: Oct 2, 2026, 4:00 PM EDT
4.320
-0.070 (-1.59%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $646.2 million as of October 2, 2026. Its market cap has increased by 218.98% in one year.
Market Cap
646.20M
Enterprise Value
477.43M
1-Year Change
218.98%
Ranking
Category
Stock Price
$4.39
ChartMarket Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $646.20M, an increase of 201.33%. That is a compound annual growth rate of 10.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 646.20M | 98.15% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 686.48M |
| MiMedx Group | 676.33M |
| Nuvectis Pharma | 675.09M |
| Electra Therapeutics | 670.35M |
| Sagimet Biosciences | 664.41M |
| DBV Technologies | 653.00M |
| Silence Therapeutics | 644.84M |
| Climb Bio | 635.82M |